Sodium-glucose cotransporter-2 inhibitors in non-diabetic patients: is there a perioperative risk of euglycaemic ketoacidosis

2. Classification and Diagnosis of Diabetes: <i>Standards of Medical Care in Diabetes—2022</i>

American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792 · see citing works

Empagliflozin in Patients with Chronic Kidney Disease

The EMPA-KIDNEY Collaborative Group (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2204233 · Cited by 2,754 · see citing works

2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery

Halvorsen, S., Mehilli, J., Cassese, S., Hall, T. S., Abdelhamid, M., Barbato, E., Hert, S. G. D., de Laval, I., Geisler, T., Hinterbuchner, L., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac270 · Cited by 1,219 · see citing works

Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes

Ferrannini, E., Baldi, S., Frascerra, S., Astiarraga, B., Heise, T., Bizzotto, R., Mari, A., Pieber, T. R., & Muscelli, E. (2016) · Diabetes · doi:10.2337/db15-1356 · Cited by 713 · see citing works

Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review

Thiruvenkatarajan, V., Meyer, E. J., Nanjappa, N., van Wijk, R. M. A. W., & Jesudason, D. R. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.03.028 · Cited by 195 · see citing works

Euglycemic diabetic ketoacidosis

Barski, L., Eshkoli, T., Brandstaetter, E., & Jotkowitz, A. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.03.014 · Cited by 176 · see citing works

Glycemic Control in the Intensive Care Unit and during the Postoperative Period

Lena, D., Kalfon, P., Preiser, J., Ichaï, C., & Riou, B. (2011) · Anesthesiology · doi:10.1097/aln.0b013e3182078843 · Cited by 67 · see citing works

Dose-dependent relationship between SGLT2 inhibitor hold time and risk for postoperative anion gap acidosis: a single-centre retrospective analysis

Steinhorn, B., & Wiener-Kronish, J. (2023) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.06.063 · Cited by 34 · see citing works

Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter-2 Inhibitors After Cardiac Surgery: A Review of Current Literature

Branco, A., Fatima, R., Liblik, K., Jackson, R., Payne, D. M., & El-Diasty, M. M. (2022) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2022.06.008 · Cited by 23 · see citing works

Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association

El‐Boghdadly, K., Dhesi, J., Fabb, P., Levy, N., Lobo, D. N., McKechnie, A., Mustafa, O., Newland‐Jones, P., Patel, A., Pournaras, D. J., et al. (2025) · Anaesthesia · doi:10.1111/anae.16541 · Cited by 147 · see citing works

Perioperative use of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes mellitus

Dhatariya, K., Levy, N., Russon, K., Patel, A., Frank, C., Mustafa, O. G., Newland‐Jones, P., Rayman, G. A., Tinsley, S. L., & Dhesi, J. K. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.12.015 · Cited by 39 · see citing works

Risk of perioperative discontinuation of SGLT2 inhibitors

Oosterom-Eijmael, M. J. P., Hermanides, J., van Raalte, D. H., & Hulst, A. H. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.05.004 · Cited by 32 · see citing works

Perioperative management of patients taking sodium-glucose cotransporter 2 inhibitors: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement

Oprea, A. D., Mohamed, B. A., Hepner, D. L., Auron, M., Richman, D. C., Umpierrez, G. E., Edmonston, D. L., Ionescu, C., Kumar, M., & Sweitzer, B. (2026) · British Journal of Anaesthesia · doi:10.1016/j.bja.2026.02.031 · Cited by 23 · see citing works

A review of the safety of sodium‐glucose co‐transporter‐2 inhibitors

O’Hara, D. V., & Jardine, M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16385 · Cited by 22 · see citing works

Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms

Goldenberg, R., Gilbert, J. D., Houlden, R. L., Khan, T., Makhija, S., Mazer, C. D., Trinacty, J., & Verma, S. (2025) · Current Medical Research and Opinion · doi:10.1080/03007995.2025.2458538 · Cited by 19 · see citing works

Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety

Zhang, B., & Deng, L. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1574693 · Cited by 13 · see citing works

Preoperative SGLT-2 inhibitor use and risk of adverse postoperative events: a single-centre retrospective observational study

Tenge, T., Roth, S., Ahrens, E., Wachtendorf, L. J., Paschold, B., Chen, G., M’Pembele, R., Kindgen‐Milles, D., Katsiampoura, A. D., Kienbaum, P., et al. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.12.024 · Cited by 7 · see citing works

Heart failure with preserved ejection fraction: implications for anaesthesia

Shah, A. M., Sabharwal, N. K., & Day, J. R. (2024) · BJA Education · doi:10.1016/j.bjae.2024.02.003 · Cited by 5 · see citing works

Euglycaemic diabetic ketoacidosis and its risk factors in patients undergoing coronary artery bypass grafting surgery: a single-centre nested case-control study in China

Hu, R., Lu, C., Liu, Y., Yang, M., Xing, H., Dai, K., Li, J., Zheng, H. W., Chen, X., & Tang, N. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-098758 · Cited by 3 · see citing works

Advances in Cardiovascular Pharmacotherapy. IV. Sodium-Glucose Cotransporter Type 2 Inhibitors, Part 2: Mechanisms for Myocardial Protection, Adverse Effects, and Perioperative Implications

Pagel, P. S., Hang, D., Freed, J. K., & Crystal, G. J. (2025) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2025.06.015 · Cited by 2 · see citing works

Sodium-glucose cotransporter2 inhibitor-associated ketoacidosis in nondiabetic patients

Stöllberger, C., Wilfing, R., Finsterer, J., & Schneider, B. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.02.003 · Cited by 1 · see citing works

Perioperative Medication Management for Patients with Diabetes

Duggan, E. W., & Mazer, C. D. (2026) · Medical Clinics of North America · doi:10.1016/j.mcna.2025.11.010 · Cited by 1 · see citing works

Before you start: the safety of SGLT2 inhibitors for anti-obesity treatment

Meslamani, A. Z. A. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2573368 · Cited by 2 · see citing works

Dapagliflozin

(2024) · Reactions Weekly · doi:10.1007/s40278-024-71838-9

Sodium‐glucose co‐transporter type‐2 inhibitors: pharmacology and peri‐operative considerations

Milder, D. A., Milder, T. Y., & Kam, P. C. A. (2018) · Anaesthesia · doi:10.1111/anae.14251 · Cited by 91 · see citing works

The catabolic triad: case report of fasting, major cardiac surgery and sodium–glucose co-transporter 2 inhibitors leading to perioperative euglycaemic ketoacidosis

Smyth, C. C., Collins, M., McCarthy, J., & Galvin, S. (2021) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivab104 · Cited by 4 · see citing works

Sodium‐glucose co‐transporter type‐2 inhibitors: is the message getting through?

Charlesworth, M., Feddy, L., & Wisely, N. A. (2019) · Anaesthesia · doi:10.1111/anae.14619 · Cited by 2 · see citing works

Sodium–glucose co-transporter-2 inhibitors and the risk of perioperative euglycaemic diabetic ketoacidosis

Williams, S. P., Stevens, J. L., & Rajendran, Y. K. (2022) · British Journal of Hospital Medicine · doi:10.12968/hmed.2022.0398 · Cited by 1 · see citing works

Sodium-glucose Cotransporter-2 Inhibitors and Euglycaemic Diabetic Ketoacidosis in the Perioperative Period: Case Report

Jhaveri, U., & Vardesh, D. L. (2019) · Cureus · doi:10.7759/cureus.5455 · Cited by 7 · see citing works